CN Stock MarketDetailed Quotes

002873 Guiyang Xintian Pharmaceutical

Watchlist
  • 11.86
  • -0.16-1.33%
Trading May 13 13:21 CST
2.75BMarket Cap38.51P/E (TTM)

Guiyang Xintian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guiyang Xintian Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

177.32M

-15.06%
EPS(YoY)

0.06

-39.08%
Analyst Rating

Strong Buy

May 13, 2024

Guiyang Xintian Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.192B--
--2024/FY-- / 1.063B--
--2023/FY953.982M / 1.307B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.192B--
--2024/FY-- / 1.063B--
--2023/FY953.982M / 1.307B--

Guiyang Xintian Pharmaceutical Earnings Reports

  • Guiyang Xintian Pharmaceutical: 2024 First Quarter Report

    Apr 27 00:00

  • Xintian Pharmaceutical: 2023 Annual Report

    Apr 12 00:00

  • Xintian Pharmaceutical: 2023 Annual Report Summary

    Apr 12 00:00

  • Xintian Pharmaceutical: Report for the third quarter of 2023

    Oct 30, 2023 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 13, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg